SWS Medical(SH:688410) Sou Hu Cai Jing·2025-08-15 12:39Core Viewpoint - The company, Chongqing Shanwaishan Blood Purification Technology Co., Ltd., is experiencing growth in its stock price and financial performance, indicating a strong position within the blood purification equipment and services industry. Group 1: Company Overview - The main business of the company includes the research, production, and sales of blood purification equipment and consumables, as well as providing chain dialysis medical services [2] - Key products include blood perfusion machines, continuous blood purification devices, dialysis machines, and various dialysis consumables [2] - The company has received multiple national and provincial awards for its technological innovations and is recognized as a national-level innovative enterprise by the Ministry of Science and Technology [2] Group 2: Financial Performance - For the first quarter of 2025, the company reported a revenue of 189 million yuan, representing a year-on-year increase of 16.77% [2] - The net profit for the same period was approximately 37.01 million yuan, with a year-on-year growth of 8.10% [2] - The sales gross margin stood at 46.72% [2] Group 3: Market Position - As of August 15, the company's stock closed at 17.36 yuan, with a price-to-earnings (PE) ratio of 75.73, significantly higher than the industry average of 56.58 [1][3] - The total market capitalization of the company is approximately 5.578 billion yuan [1] - The company ranks 95th in terms of PE ratio within its industry, which has a median PE of 39.97 [1][3] Group 4: Shareholder Information - As of March 31, 2025, the number of shareholders increased to 7,938, with an average holding value of 352,800 yuan per shareholder [1] - The average number of shares held per shareholder is 27,600 [1]